A Study of TG103 Injection in Non-diabetic Overweight or Obesity

NCT05997576 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

675

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: TG103 22.5 mg
DRUG: Placebo

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.